• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of clinical psychiatry >Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies.
【24h】

Widespread underrecognition and undertreatment of anxiety and mood disorders: results from 3 European studies.

机译：广泛的对焦虑和情绪障碍的认识不足和治疗不足：来自3项欧洲研究的结果。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Data from the World Health Organization (WHO) Collaborative Study on Psychological Problems in General Health Care, which was conducted in 26,422 primary care attendees in 14 countries worldwide, and from the Institut National de la Sante et de la Recherche Medicale (INSERM) study, which was conducted in over 2400 consecutive primary care patients in France, demonstrate the high prevalence of major depression in general practice (13.7% and 14.0% in each study, respectively). These 2 studies are supported by the more recent European Study of the Epidemiology of Mental Disorders (ESEMeD), which was conducted in over 21,400 adults from the general populations of 6 European countries and which revealed a lifetime prevalence rate for major depression of 13.4%. Despite this high prevalence, both the WHO and INSERM studies revealed that only 54% to 58% of depressed patients were recognized as "psychiatric cases" by their general practitioner and only 15% to 26% were given a specific diagnosis of depression. Even when cases were recognized, treatment was frequently inappropriate. In the WHO study, only 43% of patients correctly diagnosed with depression by their general practitioner were prescribed an antidepressant, and only 31% of patients recognized as "anxious" received an anxiolytic agent (14% were prescribed an antidepressant). In the ESEMeD study, only 4.6% of adults diagnosed with depression were using antidepressants exclusively, and 18.4% had used anxiolytic medications exclusively. The willingness to prescribe antidepressants and anxiolytic agents is influenced, in part, by diagnosis, patient age and gender, comorbidity (and severity), and the number of spontaneous psychological complaints.
机译：世界卫生组织（WHO）在全球14个国家/地区的26,422名初级保健参与者中进行的有关一般卫生保健中的心理学问题的合作研究，以及来自国立卫生研究院和研究机构的研究，该研究在法国连续对2400多名初级保健患者进行，表明在一般实践中严重抑郁症的患病率很高（每项研究分别为13.7％和14.0％）。这两项研究得到了最近的《欧洲精神疾病流行病学研究》（ESEMeD）的支持，该研究在来自6个欧洲国家的普通人群中的21,400多名成年人中进行，该研究表明，重度抑郁症的终生患病率为13.4％。尽管患病率很高，但WHO和INSERM的研究均显示，全科医生仅将54％至58％的抑郁症患者识别为“精神病患者”，并且只有15％至26％的患者被诊断出患有抑郁症。即使发现病例，治疗也常常是不合适的。在WHO的研究中，只有43％的普通医生正确诊断出患有抑郁症的患者开了抗抑郁药，只有31％的被认为是“焦虑”的患者接受了抗焦虑药（14％的患者开了抗抑郁药）。在ESEMeD研究中，只有4.6％的被诊断为抑郁症的成年人专门使用抗抑郁药，而18.4％的成年人专门使用抗焦虑药。开处方抗抑郁药和抗焦虑药的意愿在一定程度上受到诊断，患者年龄和性别，合并症（和严重性）以及自发性心理不适的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号